133 related articles for article (PubMed ID: 32231727)
1. MicroRNA-129-2-3p directly targets Wip1 to suppress the proliferation and invasion of intrahepatic cholangiocarcinoma.
Chen C; Jiang J; Fang M; Zhou L; Chen Y; Zhou J; Song Y; Kong G; Zhang B; Jiang B; Li H; Peng C; Liu S
J Cancer; 2020; 11(11):3216-3224. PubMed ID: 32231727
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA-193-3p inhibits the progression of intrahepatic cholangiocarcinoma cells by upregulating TGFBR3.
Han YL; Yin JJ; Cong JJ
Exp Ther Med; 2018 May; 15(5):4508-4514. PubMed ID: 29725386
[TBL] [Abstract][Full Text] [Related]
3. MiR-19b-3p facilitates the proliferation and epithelial-mesenchymal transition, and inhibits the apoptosis of intrahepatic cholangiocarcinoma by suppressing coiled-coil domain containing 6.
Tang Y; Yang J; Wang Y; Tang Z; Liu S; Tang Y
Arch Biochem Biophys; 2020 Jun; 686():108367. PubMed ID: 32315652
[TBL] [Abstract][Full Text] [Related]
4. MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.
Zu C; Liu S; Cao W; Liu Z; Qiang H; Li Y; Cheng C; Ji L; Li J; Li J
Oncotarget; 2017 May; 8(21):34698-34708. PubMed ID: 28423728
[TBL] [Abstract][Full Text] [Related]
5. Molecular Pathogenesis and Regulation of the
Hozaka Y; Seki N; Tanaka T; Asai S; Moriya S; Idichi T; Wada M; Tanoue K; Kawasaki Y; Mataki Y; Kurahara H; Ohtsuka T
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199886
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-212 targets FOXA1 and suppresses the proliferation and invasion of intrahepatic cholangiocarcinoma cells.
Zhu L; Huang F; Deng G; Nie W; Huang W; Xu H; Zheng S; Yi Z; Wan T
Exp Ther Med; 2016 Dec; 12(6):3790-3796. PubMed ID: 28105112
[TBL] [Abstract][Full Text] [Related]
7. Wip1 is associated with tumorigenity and metastasis through MMP-2 in human intrahepatic cholangiocarcinoma.
Liu S; Jiang B; Li H; He Z; Lv P; Peng C; Wang Y; Cheng W; Xu Z; Chen W; Liu Z; Zhang B; Shen S; Xiang S
Oncotarget; 2017 Aug; 8(34):56672-56683. PubMed ID: 28915621
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA-PAICC Promotes the Tumorigenesis of Human Intrahepatic Cholangiocarcinoma by Increasing YAP1 Transcription.
Xia L; Chen X; Yang J; Zhu S; Zhang L; Yin Q; Hong Y; Chen H; Chen G; Li H
Front Oncol; 2020; 10():595533. PubMed ID: 33552968
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY
Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-329-3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
Li W; Liang J; Zhang Z; Lou H; Zhao L; Xu Y; Ou R
Oncol Rep; 2017 May; 37(5):2743-2750. PubMed ID: 28393232
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA UCA1 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells through targeting microRNA-122.
Li O; Yi W; Yang P; Guo C; Peng C
Exp Ther Med; 2019 Jul; 18(1):25-32. PubMed ID: 31258634
[TBL] [Abstract][Full Text] [Related]
13. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-mediated miR-212-3p downregulation enhances progression of intrahepatic cholangiocarcinoma through upregulation of Rab1a.
Hou P; Kang Y; Luo J
Cancer Biol Ther; 2018; 19(11):984-993. PubMed ID: 29672195
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-301b-3p accelerates the growth of gastric cancer cells by targeting zinc finger and BTB domain containing 4.
Fan H; Jin X; Liao C; Qiao L; Zhao W
Pathol Res Pract; 2019 Nov; 215(11):152667. PubMed ID: 31585814
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-542-3p suppresses tumor cell proliferation via targeting Smad2 inhuman osteosarcoma.
Wu Y; You J; Li F; Wang F; Wang Y
Oncol Lett; 2018 May; 15(5):6895-6902. PubMed ID: 29731864
[TBL] [Abstract][Full Text] [Related]
17. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
18. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
19. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
[TBL] [Abstract][Full Text] [Related]
20. miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
Wu J; Yang B; Zhang Y; Feng X; He B; Xie H; Zhou L; Wu J; Zheng S
Int J Biol Sci; 2019; 15(8):1591-1599. PubMed ID: 31360102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
